Renee D Gala's Net Worth
$14.7 Million
Who is Renee D Gala?
Renee D Gala has an estimated net worth of $14.7 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., Gossamer Bio, Inc., CORCEPT THERAPEUTICS INC, and Jazz Pharmaceuticals plc.
SEC CIK
Renee D Gala's CIK is 0001607737
Past Insider Trading and Trends
2018 was Renee D Gala's most active year for acquiring shares with 5 total transactions. Renee D Gala's most active month to acquire stocks was the month of May. 2018 was Renee D Gala's most active year for disposing of shares, totalling 8 transactions. Renee D Gala's most active month to dispose stocks was the month of July. 2018 saw Renee D Gala paying a total of $155,101.50 for 77,750 shares, this is the most they've acquired in one year. In 2018 Renee D Gala cashed out on 93,752 shares for a total of $2,433,926.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
SVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.07% | -6.70K |
$24.79 | -$166,018.63 | 157.66K |
Nov 20
| |||
Form 4
| -3.91% | -6.70K |
$26.95 | -$180,430.25 | 164.35K |
Aug 20
| |||
Form 4
| -20.37% | -43.74K |
$26.79 | -$1,171,791.02 | 171.05K |
Aug 14 - Aug 15
| |||
Form 4
| -12.69% | -31.23K |
$24.30 | -$758,978.30 | 214.79K |
May 18 - May 20
| |||
Form 4
| +15.90% | 33.75K |
—
|
—
| 246.02K |
May 14
| |||
Form 4
| -2.48% | -5.39K |
$29.09 | -$156,707.83 | 211.41K |
Feb 20
| |||
Form 4
| +4.33% | 9K |
—
|
—
| 216.79K |
Feb 12
| |||
Form 4
| -3.15% | -6.75K |
$28.58 | -$193,000.74 | 207.79K |
Nov 20
| |||
Form 4
| -3.05% | -6.75K |
$27.40 | -$185,004.80 | 214.55K |
Aug 20
| |||
Form 4
| -2.96% | -6.75K |
$36.83 | -$248,712.99 | 221.3K |
May 20
| |||
Form 4
| -4.32% | -10.21K |
$33.78 | -$344,927.58 | 226.35K |
Feb 20
| |||
Form 4
| +3.95% | 9K |
—
|
—
| 236.56K |
Feb 6
| |||
Form 4
| -1.99% | -4.63K |
$31.96 | -$147,910.88 | 227.56K |
Nov 20
| |||
Form 4
| -1.82% | -4.31K |
$27.89 | -$120,094.34 | 232.19K |
Aug 20
| |||
Form 4
| -1.39% | -3.33K |
$20.55 | -$68,493.15 | 236.5K |
May 20
| |||
Form 4
| +60.76% | 90K |
—
|
—
| 238.13K |
Mar 15
| |||
Form 4
| -8.10% | -13.05K |
$15.65 | -$204,263.80 | 148.13K |
Feb 20
| |||
Form 4
| +3.27% | 10K |
$12.18 | $121,750.00 | 315.46K |
Aug 13 - Aug 17
| |||
Form 4
| +945.44% | 135K |
—
|
—
| 149.28K |
Feb 5
| |||
Form 4
| -1.09% | -158.00 |
$26.98 | -$4,262.84 | 14.28K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $34.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
∞
| 10K |
$15.51 | $155,101.50 | 10K |
Mar 6 - Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
President & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.04% | -1.74K |
$115.21 | -$200,004.56 | 55.36K |
Apr 5
| |||
Form 4
| -5.97% | -3.62K |
$117.53 | -$425,693.66 | 57.09K |
Mar 5
| |||
Form 4
| +48.81% | 19.92K |
—
|
—
| 60.72K |
Mar 1
| |||
Form 4
| +10.49% | 3.88K |
$119.13 | -$381,692.52 | 40.8K |
Jan 17
| |||
Form 4
| +2.14% | 772 |
—
|
—
| 36.89K |
Nov 10
| |||
Form 4
| -14.29% | -6.00K |
$131.75 | -$790,474.20 | 35.98K |
May 18
| |||
Form 4
| -4.13% | -1.81K |
$145.78 | -$263,424.46 | 41.98K |
Apr 5
| |||
Form 4
| +34.48% | 11.23K |
$142.78 | -$222,308.46 | 43.78K |
Mar 3 - Mar 5
| |||
Form 4
| -7.49% | -2.63K |
$160.00 | -$421,600.00 | 32.56K |
Scheduled
|
Dec 21
| ||
Form 4
| -4.46% | -1.63K |
$162.88 | -$265,983.04 | 34.99K |
Apr 5
| |||
Form 4
| +42.98% | 11.01K |
$153.96 | -$110,851.20 | 36.63K |
Mar 3 - Mar 5
| |||
Form 4
| -5.64% | -1.51K |
$164.71 | -$249,535.65 | 25.35K |
Apr 5
| |||
Form 4
| +60.40% | 10.12K |
—
|
—
| 26.86K |
Feb 25
| |||
Form 4
|
∞
| 16.6K |
—
|
—
| 16.6K |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||